IMR Press / FBL / Volume 27 / Issue 9 / DOI: 10.31083/j.fbl2709261
Open Access Original Research
Human Parvovirus B19 Nonstructural Protein 1 Regulates GATA1 Expression via the Notch Signaling Pathway in K562 Cell Line
Show Less
1 Department of Pediatrics, Children's Digital Health and Data Center, Zhongnan Hospital of Wuhan University, 430031 Wuhan, Hubei, China
*Correspondence: (Dongchi Zhao)
These authors contributed equally.

Academic Editor: Ioanna-Katerina Aggeli
Front. Biosci. (Landmark Ed) 2022, 27(9), 261;
Submitted: 9 May 2022 | Revised: 18 July 2022 | Accepted: 27 July 2022 | Published: 16 September 2022
(This article belongs to the Special Issue Signal Transduction and Gene Expression for Modeling Human Diseases)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.

Background: Human parvovirus B19 (B19) infection can affect the hematopoietic arrest in fetus by hindering the differentiation and maturation of erythroid progenitor cells. B19 nonstructural protein 1 (NS1) has been shown to inhibit the differentiation of erythroid progenitor cells. The goal of this study is to explore the role of B19 NS1 in the regulation of GATA1 and Notch signaling pathway in hematopoietic cells. Methods: The B19 NS1 expression plasmid was reconstituted, and the possibility of NS1 regulating GATA1 and GATA2 expression modulated by Notch-Hes pathway was tested by qRT-PCR and western blot. Immunofluorescence assays were conducted to visualize pNS1 in K562 cells. Results: We demonstrate that B19 NS1 inhibited GATA1 and induced Hes1/Hes5, which is involved in the activation of Notch signaling pathway. Meanwhile, NS1 exhibited promoting effects on GATA2 expression. Activation of the Notch signaling pathway up-regulated its downstream transcriptional repressor family Hes, thereby inhibiting the expression of GATA gene in K562 cells. Conclusions: The results show that B19 NS1 protein negatively regulates GATA1 related nuclear transcription and may interfere with hematopoietic cell differentiation.

human parvovirus B19
nonstructural protein 1
hematopoietic cells

Graphical Abstract. Putative pathway of B19 NS1 regulating EPCs differentiation. B19 NS1 activates the Notch1 signaling pathway in the cytoplasm by upregulating the expression of the intracellular domain of Notch1 to permit the transcription of its downstream target gene Hes1, and then inhibit the expression of GATA1, while NS1 may inhibit the expression of GATA1 by directly in the nucleus.

1. Introduction

Human parvovirus B19 is endemic worldwide and causes several self-limited clinical diseases such as erythema infectiosum (fifth disease) and arthritis [1, 2, 3]. The target cells of B19 are the burst-forming unit-erythroid (BFU-E) and colony forming unit-erythroid (CFU-E) progenitors. Being the most common cause of rash in school children, B19 infection can also cause aplastic crisis of erythroid progenitor cells (EPCs) in immunodeficient patients, leading to acute and chronic anemia [4, 5]. Pregnancy infection usually lead to abortion, non immune fetal edema and fetal anemia [6].

Parvovirus B19 is the smallest DNA virus in the genus Erythroparvovirus of the family Parvoviridae, which composes of a non-enveloped capsid. The genome of Parvovirus B19 consists of a single-stranded DNA and encodes two structural proteins VP1 and VP2, a major nonstructural protein NS1, and the other two small proteins of 7.5 KD and 11 KD respectively [6, 7, 8, 9, 10]. NS1 plays a role in viral replication and induces EPCs apoptosis or lysis [2, 3, 10, 11, 12, 13, 14, 15, 16]. The exploration of NS1-transgenic mice exhibits that NS1 reduces the number of erythrocytes in the fetal liver and causes fetal edema [17, 18]. However, it is still unclear how NS1 inhibits erythroid cell differentiation and maturation, thus causing aplastic crisis. GATA1 and GATA2 are prototypical transcription factors that regulate multiple gene expression in erythroid lineage cells [8, 19, 20]. In embryos lacking transcription factor GATA1, the development of embryonic red cell precursors arrested at an early proerythroblast-like stage of maturation [21]. GATA2 is necessary for the self-renewal of adult hematopoietic stem cells and is involved in the generation of hematopoietic stem/progenitor cells during mouse embryonic hematopoiesis [7].

The Notch signaling pathway participates in the regulation of the hematopoietic differentiation through intercellular interaction [22]. In mammals, Notch signaling pathway consists of four Notch receptors (Notch1, 2, 3, and 4), five Notch ligands (Delta-like1, 3, and 4 and Jagged 1 and 2). Activation of the Notch1 pathway has been proved to inhibit primitive erythropoiesis. Through the activation between Notch ligands and its receptors, the cleavage Notch intracellular domain (NICD) can be released and translocated into the nucleus, binding to recombination signal sequence-binding protein Jk (RBPJ) and then regulates the transcription of downstream genes [13]. Hairy enhancer of split (Hes) acts as a primary Notch effector, and the embryos deficient for Hes1 and Hes5 present a total absence of hematopoietic stem cell activity [23].

Thus, we speculated that B19 NS1 might regulate the Notch signal activation to inhibit GATA via Hes signaling pathway. In this study, we utilized the permissive K562 cells transfected with plasmid loading B19 NS1 as an experimental model to test this hypothesis.

2. Materials and Methods
2.1 B19 NS1 Plasmid and Cells

K562 cells (human myelogenous leukemia cell line) were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in RPMI-1640 medium (Hyclon, USA) supplemented with 10% fetal bovine serum (Serapro, USA) and 1% penicillin/streptavidin (Invitrogen, China) and maintained in a humidified incubator at 37 °C under a 5% CO2. Recombinant plasmid for B19 NS1 (pNS1) was designed according to the sequence of B19 NS1 open reading frames (NCBI, Gene ID:1489597). The synthesized sequences of NS1 were subsequently cloned into the plasmid pCMC-C-HA (Beyotime, China), which contains the fusion protein of influenza hemagglutinin (HA) tag. The pNS1-HA was transiently transduced into K562 cells with ViaFect™ Transfection Reagent (Promega, USA) according to the manufacturer’s instructions. Briefly, cells were seeded into 12-well plates (50,000 cells per well), and then a mixture of plasmid (1.5 μg) and ViaFect™ Transfection Reagent (3 μL) was incubated at room temperature for 20 min and then added to each well. The transfected cells were placed in a 5% CO2 incubator at 37 °C for the indicated time before harvest.

2.2 Small Interfering RNA (siRNA) Transfection

To block Notch1 or Hes1/Hes5 signaling, K562 cells were transduced with Notch1 or Hes1/Hes5 siRNAs (GenePharma, Shanghai, China). The siRNA sequences are listed in Table 1. K562 cells were seeded in 6-well plates (1 × 106 cells per well) and then treated with Notch1 siRNA or Hes1/Hes5 siRNA or control siRNA (NC, the siRNA which does not match any known mammalian GenBank sequences). Cells were transiently transfected with siRNA using Lipofectamine™ 3000 Transfection Reagent (Invitrogen, Carlsbad, CA, USA). The culture media was changed 8 h after transfection. Cells were harvested 24 h post-infection for further analysis.

Table 1.Sequences of siRNAs.
Gene Sequences
2.3 Immunofluorescence

Immunofluorescence assays were conducted to visualize pNS1 in K562 cells. After transfection of a recombinant plasmid, K562 cells were cultured for 24 h and fixed with 4% paraformaldehyde. The fixed cells were incubated with anti-HA (1:200; Invitrogen, Carlsbad, CA, USA) for 12 h at 4 °C and then incubated in CY3 (red)-conjugated goat anti-rabbit IgG (1:300; Invitrogen, China) for 1h. The nuclei were stained blue with 4’, 6-diamidino-2-phenylindole (DAPI) (Servicebio, China). The stained cells were observed under a FluoView 1000 laser scanning confocal microscope (Olympus, Japan).

2.4 Quantitative Real-Time PCR (qRT-PCR) Analysis

To quantify the expression of the genes of interest, total RNA was isolated from cultured cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA), and cDNA was synthesized from 1 μg of total RNA using Moloney murine leukemia virus (MMLV) reverse transcriptase ((Invitrogen, Carlsbad, CA, USA) and oligo(dT)18 as the primer. qRT-PCR was carried out using FastStart Universal SYBR Green Master (Rox, Roche) in a Real-Time PCR system (BIORAD, USA). Each sample hole of real-time PCR (20.0 μL) contained 2.0 μL of cDNA, 10.0 μL of 2X SYBR PCR Mix, 7.2 μL nuclease-free water and primers at a final concentration of 0.2 μM. The relative expression of mRNA was determined using the 2-ΔΔCt method from the threshold cycle (Ct) value. Briefly, the Ct value in each sample was standardized against the Ct value of GAPDH and was presented as a relative value (ΔCt). All standards and samples were assayed in triplicate. The primer sequences used to amplify specific target genes are listed in Table 2.

Table 2.Primer sequence for quantitative real-time PCR.
Gene Primer sequence
2.5 Western Blot

Cells were lysed using RIPA lysis buffer (Servicebio, China) containing protease and phosphatase inhibitors (Roche, Mannheim, Germany) for 30 min in ice-bath to extract the total protein. The protein concentrations were determined using a protein assay kit (Beyotime Institute of Biotechnology, Shanghai, China). The lysates were separated on SDS-PAGE gels followed by electroblotting to polyvinylidene fluoride membranes (Millipore, Billerica, MA). The blotted membranes were blocked and subsequently incubated with rabbit monoclonal anti-GATA1 (1:1000), monoclonal anti-GATA2 (1:1000), monoclonal anti-Notch1 (1:1000), monoclonal anti-Hes1 (1:1000), monoclonal anti-hes5 (1:1000), monoclonal anti-RBPJ (1:1000) and monoclonal anti-β-actin (1:1000) according to the manufacturer’s instructions. After incubation with horseradish peroxidase-labeled secondary antibody (1:3000), the membrane was reacted with the ECL substrate solution (Servicebio, China). Immunoblotting with anti-actin antibody was used as an internal control to confirm equivalent protein loading. All antibodies above were purchased from Cell Signaling Technology (CST, Boston, MA, USA).

2.6 Statistical Analyses

The results are expressed as the mean ± standard error (SE). SPSS version 25.0 software (SPSS for Windows, Inc., Chicago, IL, USA) was used for all statistical analyses. Differences between two means were analyzed using paired t-test, ANOVA was used to test the significance of the mean difference between more than two samples, least significant difference t-test (LSD t-test) was used to the ANOVA analyses post hoc test and, p < 0.05 was considered to be significant.

3. Results
3.1 Expression and Identification of the NS1 Plasmid

pNS1 was transferred into Escherichia coli DH5-α and the positive colonies were identified. Then the positive clones were digested with restriction endonucleases, and separated through electrophoresis on a 1% agarose gel. The expected NS1 fragment was obtained with base sizes of 2031 bp through electrophoresis (Fig. 1A). After transfections of the pNS1, protein from K562 cells were extracted for western blot analysis. A band of ~78 KD, corresponding to the size of the NS1-HA fusion protein, was detected (Fig. 1B).

Fig. 1.

Expression of reconstruction B19 NS1. (A) Digestion of pCMV-HA vector and NS1-expressing plasmid (pNS1-HA) with restriction enzyme BamHI and XbaI for 1h. The expected NS1 fragment was obtained, with a base size of 2031bp in pNS1-HA plasmid transfected group. (B) pNS1 was transfected into K562 cells, western blotting shows that NS1-HA protein, the molecular weight ~78 KD.

3.2 NS1 Localizes Both in the Nucleus and Cytoplasm

The localization of NS1 protein in pNS1 transfected cells was detected by immunofluorescence. 24 hours after pNS1 transfection, the K562 cells were treated with anti-HA and anti-CY3 antibodies. Under confocal microscope, the cells transfected with pNS1 had obvious CY3 fluorescence, while the control cells had no signal. The CY3 fluorescence signal is overlapped with the nucleus (Blue), the intensity and the area of the CY3 fluorescence signal of the overlapping part was larger than that of the nonoverlapping part, indicating that the B19 NS1 protein was mainly expressed in the nucleus, a few in the cytoplasm (Fig. 2).

Fig. 2.

NS1-HA localizes in the cytoplasm and the nucleus. K562 cells were transfected with pNS1 and then cultured for 24 h. Blank cells without plasmid were used as controls. After fixed with 4% paraformaldehyde, the cells were first incubated with 1:200 anti-HA for 12 h at 4 °C, then 1:300 CY3-conjugated goat anti-rabbit IgG for 1 h. The nuclei were stained blue with DAPI. The stained cells were observed under the confocal microscope. The CY3 fluorescence signals were mainly in the nucleus, a few in the cytoplasm. The data comes from one of three independent experimental results. Magnifications: 200×, scale bar = 100 μm; 400×, scale bar = 50 μm.

3.3 NS1 Modulated GATA1 and GATA2 Expression in K562 Cells

In order to verify whether B19 NS1 affects the transcription or translation of GATA1 and GATA2, the total cellular RNA and protein of pNS1 transfected cells were collected at indicated times. The expression of GATA1/GATA2 mRNAs was detected by qRT-PCR, and GATA1/GATA2 proteins were detected by western blot. The results showed that NS1 protein could be detected in a time-dependent manner after plasmids transfection, while the GATA1 and GATA2 demonstrated a different manner with the downregulation in GATA1 mRNA and upregulation in GATA2 mRNA, which was most noticeable at 24 h (Fig. 3A,B). The alteration of GATA1 and GATA2 proteins expression aligns with mRNA expression, except that the significant changes of GATA2 expression occur at 4 h after transfection while GATA1 occur at 2 h (Fig. 3C,D).

Fig. 3.

NS1 downregulated GATA1 and upregulated GATA2. (A,B) The expression of GATA1 mRNA and GATA2 mRNA was detected by qRT-PCR. Downregulated GATA1 mRNA and upregulated GATA2 mRNA were detected in cells treated with pNS1. The data were standardized against GAPDH and are presented as a relative value by calculated with the 2-ΔΔCt method, *p < 0.05, **p < 0.01, ***p < 0.001 versus 0 h after transfecting with pNS1. (C,D) K562 cells were transfected with pNS1, and then western blotting was used to detect the expression of GATA1/GATA2 protein. The data were normalized to the level of β-actin. Levels of GATA1/GATA2 relative protein in different time point after transfection were assessed when compared to blank or vetor respectively. The data are derived from the results of three independent experiments, LSD t-test after ANOVA analyses, *p < 0.05, **p < 0.01.

3.4 NS1 Activates the Notch Signaling Pathway

To determine whether the Notch signaling pathways are involved in the pathogenic mechanism of B19 NS1, NICD and its target molecules HES1 and HES5 in K562 cells were detected by western blot after transfected of pNS1, the empty vectors and blank cells without transfection were signed as controls. As shown in Fig. 4, NICD expressed at 1.5 fold higher levels in the pNS1 transfected cells than in the blank controls. Similarly, HES1 and HES5 increased in the pNS1 transfected cells than in vector controls (Fig. 4A,B). Based on these results, we conclude that the B19 NS1 could be primary pathogenic molecule involved in activating the Notch signaling pathway. To further verify this hypothesis, we detected the effector protein RBPJ in the nucleus of NICD, and designed siRNA for Notch1 to silence its target gene. It can be seen that NS1 can increase RBPJ in K562 by more than 5 times, while the K562 cells pretreated with si-Notch showed the opposite result, as the expression of RBPJ decreased (Fig. 4C,D). In addition, we also detected the mRNA expression to the transcription factors, P300, Pu.1, c-Myb, which mediating transcriptional activation from chromatin templates by NICD [4, 24]. The result shows that NS1 significantly upregulated c-Myb mRNA in K562 cells, but had no effect on the expression of P300 and Pu.1 mRNA. For K562 cells pretreated with si-Notch1, the expression of c-Myb decreased, and the expression of P300 and Pu.1 mRNA remained unchanged (Fig. 4E).

Fig. 4.

NS1 activates the Notch signaling pathway. (A,B) To analysis the expression of Notch1, Hes1, and Hes5 in the cells transfected with pNS1 or empty vectors, total proteins were extracted for western blotting 24 hours after transfection. Levels of NICD, HES1, and HES5 protein were assessed when compared to blank or vetor respectively. The results demonstrated that the expression of NICD, HES1, and HES5 protein upregulated in the cells transfected with pNS1. (C–E) The cells transfected with pNS1 vectors, as another group cells were pretreated with si-Notch1 for 24 hours, then transfected with pNS1, total proteins and RNAs were extracted 24 hours after transfection. Levels of RBPJ protein were assessed by western blotting, expression of P300, Pu.1 and c-Myb mRNA were detected by qRT-PCR, when compared to blank respectively. The data are derived from the results of three independent experiments, LSD t-test after ANOVA analyses, *p < 0.05.

3.5 NS1 Modulates “GATA Switch” by Inducing Notch Signaling Activation

In order to elucidate that B19 NS1 regulates GATA activity by manipulating Notch signaling pathway, we designed siRNA for Notch1, Hes1 and Hes5 to silence their target genes respectively. The K562 cells were respectively transfected with si-Notch1, si-Hes1, or si-Hes5 for 24 hours, and the total proteins were collected for western blot analyses. Significantly increased expression of GATA1 and GATA2 proteins were detected in si-Notch1 transfected cells, as well as in si-Hes1 or si-Hes5 transfected cells. K562 cells that had been co-transfected with si-Notch1 and si-Hes1, or co-transfected with si-Notch1 and si-Hes5 showed higher GATA1 and GATA2 expression than cells transfected with si-Notch1 or si-Hes1/Hes5 alone (Fig. 5A–C).

Fig. 5.

Inhibition of Notch-Hes signaling pathway upregulates GATA1 and GATA2 expression. The cells were transfected with si-Notch1, si-Hes1, or si-Hes5, and the total protein was collected 24 hours later for western blotting when compared to blank respectively (A–C). Then the cells were transfected with pNS1, and the total protein was extracted 24 hours after pNS1 tranfection for western blotting analysis (D–F, D compared to blank respectively, E compared to pNS1 respectively, F compared to pNS1+siHes1). The cells were pretreated with si-Notch1 for 24 hours, then transfected with pNS1. The total protein was extracted 24 hours after transfection for western blot analysis (G). The data are derived from the results of three independent experiments, LSD t-test after ANOVA analyses, *p < 0.05.

We then detected the effect of B19 NS1 on NICD, Hes1, Hes5, and GATA1 expression in the Notch1, Hes and Hes5 silenced cells. We showed that the expression of GATA1 protein was higher in pNS1+si-Notch1 and pNS1+si-Hes1 transfected cells than pNS1 alone transfected cells, while inhibition of Notch1 significantly decreased the expression of Hes1 and Hes5 induced by pNS1 (Fig. 5D,E). Both Hes1 and Hes5 were involved in pNS1 activated Notch1 signaling pathway related to the regulation of GATA1 expression. These results implied that Hes1 and Hes5 are essential regulators of GATA1 expression in Notch signaling, and the expression of Hes1 and Hes5 was negatively correlated with GATA1 activity. Inhibition of Notch could counteract the effect of NS1 on GATA1 expression, which implies that NS1 regulated GATA1 expression through up-regulating Notch1 activity. Inhibition of Hes5 could up regulate the expression of GATA1 more than inhibition of Hes1. This result implies that there might be a competitive relationship between them in regulating the expression of GATA1 (Fig. 5F).

4. Discussion

In this study, we demonstrated that B19 NS1 plays essential role in inhibiting GATA1 expression and upregulating GATA2 expression. This dynamic controlled change of expression aligns with “GATA switch” regulatory pathway which was mediated by Notch-Hes signaling. In addition, NS1 probably triggered the Notch signaling pathway to disrupt the “GATA switch” balance in K562 cells.

B19 infection can cause human transient aplastic crisis. One of the pathogenesis is explained by the cytotoxicity, which is correlated with the intracellular accumulation of the NS1 protein, and the infected erythroid-lineage cells exhibit apoptotic features [17, 25]. B19 infection often severely affects the hematopoietic function of the fetus or newborn by playing an important role in hindering the differentiation and maturation of erythroid progenitor cells. The Notch pathway plays an important role in erythroid cell proliferation and differentiation, during which several viral proteins are involved [9, 14, 26]. Activation of the Notch signaling pathway can up-regulate the transcriptional repressor family HES, thereby disturbing the balance of GATA box and inhibiting the differentiation and maturation of EPC.

In this study, we found the possible mechanism of B19-related anemia that NS1 inhibits the differentiation of hematopoietic stem cells into erythrocytes by down-regulating GATA1 and up-regulating GATA2 transcription, which is in line with an insight in our previous conjecture [27]. The evolution of erythroid cells contains the different stages including hematopoietic stem cells (HSC), common myeloid progenitors (CMP), megakaryo-erythroid progenitor (MEP), BFU-E, CFU-E, proerythroblast, erythroblast, reticulocyte, and eventually red blood cell. GATA1 factor is the first expressed at CMP stage, and gradually increases in the next phase, then reach a peak at the proerythroblast stage, and decreased as the maturation of red blood cells [11, 28]. Contrary to GATA1, GATA2 is abundantly expressed in HSC and hematopoietic progenitor cells due to its great contribution to the development and maintenance of these cells. However, the expression of GATA2 gradually declines as approaching the process of terminal erythroid differentiation [11]. The dynamic changes of GATA1 and GATA2 refer to the GATA factor switching during erythroid differentiation, that is, the expression of GATA1 rises and gradually replaces GATA2 at the same motifs to inhibit GATA2 transcription. In our experiments, NS1 downregulated GATA1 but upregulated GATA2 in the K562 cells which disrupted the “GATA switch” balance. These results suggest that NS1 could retrograde the process of erythroid cell differentiation as early hematopoietic progenitor cells. Moreover, the alteration of GATA2 expression was posterior to GATA1, we speculated that the upregulation of GATA2 was secondary to the downregulation of GATA1, rather than the direct effect of NS1.

Notch signaling pathway affects cell proliferation and differentiation, which makes the virus escaped the innate cellular antiviral response and promotes cell survival [29]. Human papillomavirus and simian virus 40 could activate the Notch pathway via increasing the expression of Notch proteins [15, 30], while Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus take part in the Notch manipulation through the combination of its encode proteins to the Notch components [31, 32].

Co-transfection experiments showed that there were no significant changes of GATA1 expression in the Notch1 or Hes1-silenced cells, while Hes5-silenced cells still showed the downregulation of GATA1, which may be due to the NS1 downregulating GATA1 through Notch1 and Hes1. In addition, co-transfection experiments showed that GATA2 upregulated in the Notch1 or Hes1/Hes5-inhibited cells, which further indicate that the changes of GATA2 in NS1 transfected cells were not mediated by the effects of NS1 on Notch1 and Hes1/Hes5. Our study showed that Notch1 enhanced the Notch intracellular effector RBPJ and the DNA-binding transcription factor c-Myb, in association with the result of immunofluorescence assay that NS1 localized both in the cytoplasm and nucleus, we came to this conception that NS1 in the cytoplasm activates the Notch1 signaling pathway by upregulating the expression of the intracellular domain of Notch1 to permit the transcription of Hes1, and then inhibit the expression of GATA1, while NS1 in the nucleus may inhibit the expression of GATA1 by directly upregulating the expression of Hes1.This provides a possible target for future prevention or treatment of B19-related anemia.

C-Myb is mainly expressed in immature hematopoietic cells and plays a role in maintaining cell proliferation and differentiation [33]. When cells began to differentiate, their expression levels were down-regulated. Hes-c-Myb complex show negative regulation in cell differentiation [34]. c-Myb binds to GATA1 promoter and inhibits c-Myb expression, leading to further differentiation of erythrocytes [35]. In our experiment, NS1 can up-regulate Hes and c-Myb and down-regulate GATA1, which is contrary to normal cell differentiation. Therefore, it is assumed that anemia caused by B19 infection is related to Hes-c-Myb complex regulation. Interestingly, some studies have shown that there is a synergistic effect between c-myb and P300 and PU.1. However, in our study, we did not find that the expressions of c-Myb, P300 and PU.1 were up-regulated at the same time after NS1 transfection. This may be related to different cell lines, and its mechanism needs to be further studied.

There are shortages in this study. Our study was based on the single NS1 protein of B19, the role of a full-length B19 virus remains to be confirmed. The reason why K562 cell line was selected was that it presented the early stage of hematopoietic progenitor cell differentiation, however, this cell line could not reveal the dynamic process of erythroid differentiation. Further experiments should be carried out for erythroid progenitor cells differentiation process to observe the dynamic expression profiles of GATA1 and GATA2 after transfecting of B19 NS1.

5. Conclusions

In summary, we found that B19 NS1 protein negatively regulates GATA1 related nuclear transcription by activating Notch1 signaling pathway or directly upregulating the expression of Hes1, which provides potential targets and new ideas for the prevention and treatment of fetal anemia, hemolysis and hematopoietic dysfunction caused by B19 infection.

Consent for Publication

Not applicable.

Data Availability Statement

The data are available from the corresponding author upon reasonable request.


B19, Human parvovirus B19; NS1, Nonstructural protein 1; BFU-E, Burst-forming unit-erythroid; CFU-E, Colony forming unit-erythroid; EPCs, Erythroid progenitor cells; NICD, Notch intracellular domain; RBPJ, Recombination signal sequence-binding protein Jk; Hes, Hairy/enhancer-of-split; DAPI, 4’, 6-diamidino-2-phenylindole; c-Myb, c-Myb transcription factor; P300, E1A binding protein p300; Pu.1, spleen focus forming virus proviral integration oncogene; HSC, Hematopoietic stem cells; CMP, Common myeloid progenitors; MEP, megakaryo-erythroid progenitor.

Author Contributions

JZ, Dongx Z and Dongc Z guided the formulation of the experimental scheme and finished the last revision of the article. SF collected the references and illustrated this paper. JZ, Dongc Z, and PF carried on the experiment operation and participated in writing and revising the paper. All authors contributed to the article and approved the submitted version.

Ethics Approval and Consent to Participate

Not applicable.


Not applicable.


This work was supported by grants from the Chinese National Natural Science Fund 81170005 and 81670007, the Scientific Project supported by the Health Commission of Hubei Province, China WJ2019M214.

Conflict of Interest

The authors declare no conflict of interest.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Colmegna I, Alberts-Grill N. Parvovirus B19: its Role in Chronic Arthritis. Rheumatic Disease Clinics of North America. 2009; 35: 95–110.
Naciute M, Mieliauskaite D, Rugiene R, Nikitenkiene R, Jancoriene L, Mauricas M, et al. Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis. Journal of General Virology. 2016; 97: 3302–3312.
Tello-Winniczuk N, Díaz-Jouanen E, Díaz-Borjón A. Parvovirus B19-Associated Arthritis: report on a community outbreak. Journal of Clinical Rheumatology. 2011; 17: 449–450.
Chen PM, Yen CC, Wang WS, Lin YJ, Chu CJ, Chiou TJ, et al. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia. International Journal of Oncology. 2008; 32: 1335–1341.
Rogo LD, Mokhtari-Azad T, Kabir MH, Rezaei F. Human parvovirus B19: a review. Acta Virologica. 2014; 58: 199–213.
Lamont R, Sobel J, Vaisbuch E, Kusanovic J, Mazaki-Tovi S, Kim S, et al. Parvovirus B19 infection in human pregnancy. BJOG: An International Journal of Obstetrics and Gynaecology. 2011; 118: 175–186.
Kitajima K, Kanokoda M, Nakajima M, Hara T. Domain-specific biological functions of the transcription factor Gata2 on hematopoietic differentiation of mouse embryonic stem cells. Genes to Cells. 2018; 23: 753–766.
Ling T, Birger Y, Stankiewicz MJ, Ben-Haim N, Kalisky T, Rein A, et al. Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesis. Blood. 2019; 134: 1619–1631.
Liu X, Jiang X, Huang S, Sun J, Zhao F, Zeng W, et al. Human cytomegalovirus infection dysregulates neural progenitor cell fate by disrupting Hes1 rhythm and down-regulating its expression. Virologica Sinica. 2017; 32: 188–198.
Luo W, Astell CR. A Novel Protein Encoded by Small RNAs of Parvovirus B19. Virology. 1993; 195: 448–455.
Moriguchi T, Yamamoto M. A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation. International Journal of Hematology. 2014; 100: 417–424.
Poole BD, Kivovich V, Gilbert L, Naides SJ. Parvovirus B19 Nonstructural Protein-Induced Damage of Cellular DNA and Resultant Apoptosis. International Journal of Medical Sciences. 2011; 8: 88–96.
Siebel C, Lendahl U. Notch Signaling in Development, Tissue Homeostasis, and Disease. Physiological Reviews. 2017; 97: 1235–1294.
Wang L, Grossman SR, Kieff E. Epstein–Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proceedings of the National Academy of Sciences of the United States of America. 2000; 97: 430–435.
Weijzen S, Zlobin A, Braid M, Miele L, Kast WM. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation. Journal of Cellular Physiology. 2003; 194: 356–362.
Xu P, Zhou Z, Xiong M, Zou W, Deng X, Ganaie SS, et al. Parvovirus B19 NS1 protein induces cell cycle arrest at G2-phase by activating the ATR-CDC25C-CDK1 pathway. PLoS Pathogens. 2017; 13: e1006266.
Chen AY, Zhang EY, Guan W, Cheng F, Kleiboeker S, Yankee TM, et al. The small 11kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood. 2010; 115: 1070–1080.
Chisaka H, Morita E, Murata K, Ishii N, Yaegashi N, Okamura K, et al. A transgenic mouse model for non-immune hydrops fetalis induced by the NS1 gene of human parvovirus B19. Journal of General Virology. 2002; 83: 273–281.
Crispino JD, Horwitz MS. GATA factor mutations in hematologic disease. Blood. 2017; 129: 2103–2110.
Richards LA, Kumari A, Knezevic K, Thoms JA, von Jonquieres G, Napier CE, et al. DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts. Haematologica. 2020; 105: 1517–1526.
Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proceedings of the National Academy of Sciences of the United States of America. 1996; 93: 12355–12358.
Bray SJ. Notch signalling: a simple pathway becomes complex. Nature Reviews Molecular Cell Biology. 2006; 7: 678–689.
Guiu J, Shimizu R, D’Altri T, Fraser ST, Hatakeyama J, Bresnick EH, et al. Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling. Journal of Experimental Medicine. 2013; 210: 71–84.
Fryer CJ, Lamar E, Turbachova I, Kintner C, Jones KA. Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes and Development. 2002; 16: 1397–1411.
Yaegashi N. Pathogenesis of Nonimmune Hydrops Fetalis Caused by Intrauterine B19 Infection. The Tohoku Journal of Experimental Medicine. 2000; 190: 65–82.
Qin L, Qiu K, Hu C, Wang L, Wu G, Tan Y. Respiratory syncytial virus promoted the differentiation of Th17 cells in airway microenvironment through activation of Notch-1/Delta3. Journal of Medical Microbiology. 2019; 68: 649–656.
Feng S, Zeng D, Zheng J, Zhao D. New Insights of Human Parvovirus B19 in Modulating Erythroid Progenitor Cell Differentiation. Viral Immunology. 2020; 33: 539–549.
Ferreira R, Ohneda K, Yamamoto M, Philipsen S. GATA1 Function, a Paradigm for Transcription Factors in Hematopoiesis. Molecular and Cellular Biology. 2005; 25: 1215–1227.
Hayward SD. Viral interactions with the Notch pathway. Seminars in Cancer Biology. 2004; 14: 387–396.
Bocchetta M, Miele L, Pass HI, Carbone M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene. 2003; 22: 81–89.
Gasperini P, Espigol-Frigole G, McCormick PJ, Salvucci O, Maric D, Uldrick TS, et al. Kaposi Sarcoma Herpesvirus Promotes Endothelial-to-Mesenchymal Transition through Notch-Dependent Signaling. Cancer Research. 2012; 72: 1157–1169.
Gunnell A, Webb HM, Wood CD, McClellan MJ, Wichaidit B, Kempkes B, et al. RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth. Nucleic Acids Research. 2016; 44: 4636–4650.
George OL, Ness SA. Situational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis. Cancers. 2014; 6: 2049–2071.
Allen RD, Kim HK, Sarafova SD, Siu G. Negative Regulation of CD4 Gene Expression by a HES-1–c-Myb Complex. Molecular and Cellular Biology. 2001; 21: 3071–3082.
Bartůnek P, Králová J, Blendinger G, Dvorák M, Zenke M. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter. Oncogene. 2003; 22: 1927–1935.
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Back to top